Author:
Choules Mary P.,Bisson Jonathan,Simmler Charlotte,McAlpine James B.,Giancaspro Gabriel,Bzhelyansky Anton,Niemitz Matthias,Pauli Guido F.
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference20 articles.
1. Residual complexity does impact organic chemistry and drug discovery: the case of rufomyazine and rufomycin;Choules;J. Org. Chem.,2018
2. Can invalid bioactives undermine natural product-based drug discovery?;Bisson;J. Med. Chem.,2016
3. Impurities in Drug Substances and Drugs Products <1086>, in: USP 42–NF 37;United States Pharmacopeia,2019
4. Residual Solvents/Organic Volatile Impurities <467>, in: USP 42-NF 37;United States Pharmacopeia,2019
5. Pharmaceutical impurities: an overview;Rama Rao;Indian J. Pharm. Educ. Res.,2010
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献